Ziprasidone

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Congenital malformations All congenital malformations (majors, minors, majors and minors, or unspecified) Huybrechts (Controls unexposed, sick), 2023 11.09[0.81; 1.46]11,638-not evaluable Congenital heart defects Huybrechts (Controls unexposed, sick), 2023 10.83[0.45; 1.54]--not evaluable Gastroschisis Huybrechts (Controls unexposed, sick), 2023 11.89[0.27; 13.32]--not evaluable Hip dislocation and/or dysplasia Huybrechts (Controls unexposed, sick), 2023 10.85[0.12; 6.03]--not evaluable Major congenital malformations Huybrechts (Controls unexposed, sick), 2023 11.09[0.81; 1.46]11,638-not evaluable Oro-facial clefts Huybrechts (Controls unexposed, sick), 2023 12.01[0.65; 6.22]--not evaluable Maternal consequences Gestational diabetes Park, 2018 10.76[0.29; 2.00]26167not evaluable Intrauterine deaths Early intrauterine deaths (< 22 weeks) / Spontaneous abortions Sorensen, 2015 11.97[1.20; 3.24]114,32541not evaluable0.020.01.0

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons